These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 17584651)
1. [Positron emission tomography with L-[S-methyl-11C]-methioine and its biodistribution]. Chen LG; Zhou MJ; Tan AW; Wang SX; He SZ; Ding ZH Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jun; 27(6):834-5. PubMed ID: 17584651 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and preliminary biological evaluation of S-11C-methyl-D-cysteine as a new amino acid PET tracer for cancer imaging. Huang T; Tang G; Wang H; Nie D; Tang X; Liang X; Hu K; Yi C; Yao B; Tang C Amino Acids; 2015 Apr; 47(4):719-27. PubMed ID: 25534431 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of F-18-labeled amino acid derivatives and [18F]FDG as PET probes in a brain tumor-bearing animal model. Wang HE; Wu SY; Chang CW; Liu RS; Hwang LC; Lee TW; Chen JC; Hwang JJ Nucl Med Biol; 2005 May; 32(4):367-75. PubMed ID: 15878506 [TBL] [Abstract][Full Text] [Related]
4. 18F-fluoro-L-thymidine and 11C-methylmethionine as markers of increased transport and proliferation in brain tumors. Jacobs AH; Thomas A; Kracht LW; Li H; Dittmar C; Garlip G; Galldiks N; Klein JC; Sobesky J; Hilker R; Vollmar S; Herholz K; Wienhard K; Heiss WD J Nucl Med; 2005 Dec; 46(12):1948-58. PubMed ID: 16330557 [TBL] [Abstract][Full Text] [Related]
5. Effect of α-Methyl versus α-Hydrogen Substitution on Brain Availability and Tumor Imaging Properties of Heptanoic [F-18]Fluoroalkyl Amino Acids for Positron Emission Tomography (PET). Bouhlel A; Alyami W; Li A; Yuan L; Rich K; McConathy J J Med Chem; 2016 Apr; 59(7):3515-31. PubMed ID: 26967318 [TBL] [Abstract][Full Text] [Related]
6. Glioma proliferation as assessed by 3'-fluoro-3'-deoxy-L-thymidine positron emission tomography in patients with newly diagnosed high-grade glioma. Ullrich R; Backes H; Li H; Kracht L; Miletic H; Kesper K; Neumaier B; Heiss WD; Wienhard K; Jacobs AH Clin Cancer Res; 2008 Apr; 14(7):2049-55. PubMed ID: 18381944 [TBL] [Abstract][Full Text] [Related]
7. Optimization of semi-quantification in metabolic PET studies with 18F-fluorodeoxyglucose and 11C-methionine in the determination of malignancy of gliomas. Borbély K; Nyáry I; Tóth M; Ericson K; Gulyás B J Neurol Sci; 2006 Jul; 246(1-2):85-94. PubMed ID: 16603193 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of pharmacokinetics of 4-borono-2-(18)F-fluoro-L-phenylalanine for boron neutron capture therapy in a glioma-bearing rat model with hyperosmolar blood-brain barrier disruption. Hsieh CH; Chen YF; Chen FD; Hwang JJ; Chen JC; Liu RS; Kai JJ; Chang CW; Wang HE J Nucl Med; 2005 Nov; 46(11):1858-65. PubMed ID: 16269600 [TBL] [Abstract][Full Text] [Related]
9. 3-[123I]iodo-alpha-methyltyrosine and [methyl-11C]-L-methionine uptake in cerebral gliomas: a comparative study using SPECT and PET. Langen KJ; Ziemons K; Kiwit JC; Herzog H; Kuwert T; Bock WJ; Stöcklin G; Feinendegen LE; Müller-Gärtner HW J Nucl Med; 1997 Apr; 38(4):517-22. PubMed ID: 9098193 [TBL] [Abstract][Full Text] [Related]
10. Analysis of 18F-FET PET for grading of recurrent gliomas: is evaluation of uptake kinetics superior to standard methods? Pöpperl G; Kreth FW; Herms J; Koch W; Mehrkens JH; Gildehaus FJ; Kretzschmar HA; Tonn JC; Tatsch K J Nucl Med; 2006 Mar; 47(3):393-403. PubMed ID: 16513607 [TBL] [Abstract][Full Text] [Related]
11. Comparison of sigma-ligands and metabolic PET tracers for differentiating tumor from inflammation. van Waarde A; Jager PL; Ishiwata K; Dierckx RA; Elsinga PH J Nucl Med; 2006 Jan; 47(1):150-4. PubMed ID: 16391199 [TBL] [Abstract][Full Text] [Related]
12. L-(methyl-11C) methionine positron emission tomography for target delineation in resected high-grade gliomas before radiotherapy. Grosu AL; Weber WA; Riedel E; Jeremic B; Nieder C; Franz M; Gumprecht H; Jaeger R; Schwaiger M; Molls M Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):64-74. PubMed ID: 16111573 [TBL] [Abstract][Full Text] [Related]
13. Diagnostic accuracy of 11C-methionine PET for differentiation of recurrent brain tumors from radiation necrosis after radiotherapy. Terakawa Y; Tsuyuguchi N; Iwai Y; Yamanaka K; Higashiyama S; Takami T; Ohata K J Nucl Med; 2008 May; 49(5):694-9. PubMed ID: 18413375 [TBL] [Abstract][Full Text] [Related]
14. Delineation of brain tumor extent with [11C]L-methionine positron emission tomography: local comparison with stereotactic histopathology. Kracht LW; Miletic H; Busch S; Jacobs AH; Voges J; Hoevels M; Klein JC; Herholz K; Heiss WD Clin Cancer Res; 2004 Nov; 10(21):7163-70. PubMed ID: 15534088 [TBL] [Abstract][Full Text] [Related]
15. [Sequential analysis of the integrated images of PET, CT and MR in malignant brain tumors before and after radiotherapy]. Suzuki A; Mineura K; Sasajima T; Kowada M; Ogawa T; Hatazawa J; Uemura K No To Shinkei; 1996 May; 48(5):449-57. PubMed ID: 8672304 [TBL] [Abstract][Full Text] [Related]
16. [Molecular imaging of epidermal growth factor receptor in glioma-bearing rats]. Wang H; Yu JM; Song XR; Yang GR; Mu DB; Zhao SQ; Wang XW; Wei L; Liu YL; Song B; Fu Z; Teng XP Zhonghua Zhong Liu Za Zhi; 2008 May; 30(5):343-6. PubMed ID: 18953832 [TBL] [Abstract][Full Text] [Related]
17. Surgical target selection in cerebral glioma surgery: linking methionine (MET) PET image fusion and neuronavigation. Roessler K; Gatterbauer B; Becherer A; Paul M; Kletter K; Prayer D; Hoeftberger R; Hainfellner J; Asenbaum S; Knosp E Minim Invasive Neurosurg; 2007 Oct; 50(5):273-80. PubMed ID: 18058643 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of brain and whole-body pharmacokinetics of 11C-labeled diphenylhydantoin in rats by means of planar positron imaging system. Hasegawa Y; Kanai Y; Hasegawa S; Okamoto T; Matsui T; Shimosegawa E; Kurachi Y; Hatazawa J Ann Nucl Med; 2008 May; 22(4):301-7. PubMed ID: 18535881 [TBL] [Abstract][Full Text] [Related]